4//SEC Filing
GREGORY JULIA P 4
Accession 0001226675-25-000004
CIK 0001549595other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 6:58 PM ET
Size
6.8 KB
Accession
0001226675-25-000004
Insider Transaction Report
Form 4
GREGORY JULIA P
Director
Transactions
- Exercise/Conversion
Common Stock
2025-09-17$1.86/sh+10,750$19,995→ 10,750 total - Exercise/Conversion
Director Stock Option (right to buy)
2025-09-17−10,750→ 22,583 totalExercise: $1.86Exp: 2029-12-22→ Common Stock (10,750 underlying)
Footnotes (1)
- [F1]The stock option vested as to 1/48 of the total shares monthly beginning September 12, 2019, and was vested in full on August 12, 2023.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001226675
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 6:58 PM ET
- Size
- 6.8 KB